Moreover, hyperglycemia in diabetes could be controlled by GNPs via improving blood glucose levels, insulin resistance, and liver enzymes, reducing proinflammatory cytokines (include TNF-α, IL-6, and CRP), and enhancing the antioxidant defense enzymes. The gene discussed is CRP; the disease is diabetes mellitus.